Illumina DNA sequencing devices could be vulnerable to hackers - FDA
JasonDoiy

The US FDA is warning that a "cybersecurity vulnerability" in software used in some of Illumina's (NASDAQ:ILMN) DNA sequencing instruments could give hackers access to the machines.
In an April 27 letter to healthcare providers, the agency noted that there have been no reports so far of any unauthorized access.

The FDA said that an unauthorized user could potentially take control of the devices remotely, alter settings or data, or otherwise alter data to provide incorrect or no results.
Instruments potentially impacted include: MiSeqDx, NextSeq 550Dx, iScan, iSeq 100, MiniSeq, MiSeq, NextSeq 500, NextSeq 550, NextSeq 1000/2000, and NovaSeq 6000.
Illumina (ILMN) has developed a software patch to remedy the issue.

More on Illumina

Illumina unveils $100M annual cost cutting plan
Carl Icahn further accuses Illumina board of 'obfuscation'
Continue To Avoid Illumina Inc